期刊文献+

中美处方药说明书中关于吸烟影响药效和药动学内容的比较

Comparison of Smoking Affecting Pharmacodynamics and Pharmacokinetics between US and Chinese Prescription Drug Instructions
下载PDF
导出
摘要 目的:比较中美处方药说明书中有关吸烟影响药效和药动学内容的差异。方法:收集中美颁布的药品研发及药品说明书编写相关指南和处方药说明书,检索截至2014年6月19日美国药品食品监督管理局药品说明书官方网站DailyMed和中国药智网中的吸烟影响药效和药动学的相关内容,比较两国相关规定以及说明书中描述的差异。结果与结论:两国颁布的指南均要求在新药研发过程中关注吸烟对药效和药动学的影响,且须在说明书中明确注明。在记录的62 857条药品中,美国说明书提示吸烟对34个药物的药效和药动学产生影响,其中9个药物需要调整用药剂量;上述药品在中国药品说明书中有6个药物提示须关注吸烟对其药效和药动学的影响,仅1个药物(盐酸厄洛替尼)提示需要调整剂量。与美国药品说明书比较,中国药品说明书在吸烟对药效和药动学方面影响的标注率明显偏低。建议药品监督管理部门规范和完善药品说明书在此方面内容的描述,对不适宜的内容作更正,对可能产生严重后果的项目进行修订,尽快建立能够提供所有药品说明书查询的官方网站;药品生产企业也应规范药品上市前的临床研究,重视药品说明书的科学性、完整性和规范性。 OBJECTIVE: To compare the difference of the information about smoking affecting pharmacodynamics and pharma- cokinetics in prescription drug instructions between US and China. METHODS: The US and Chinese guidance for drug R&D and drug instructions editing, prescription drug instructions were collected; the information about smoking affecting pharmacodynamics and pharmacokinetics were retrieved from FDA drug instruction official website DailyMed and Yaozhi Network in China up to Jun. 19th, 2014. The difference in related regulations and drug instruction were compared between US and China. RESULTS & CON- CLUSIONS: The guidance issued by US and China require that great importance should be attached to the effects of smoking on pharmacodynamics and pharmacokinetics, and it must be noted in drug instructions. Of 62 857 drugs recorded, smoking affected pharmacodynamics and pharmcokinetics of 34 drugs in US drug instructions, among which 9 drugs needed dose modifications; for above drugs, Chinese drug instructions pointed out great importance should be attached to the effect of smoking on pharmacodynam- ics and pharmacokinetics of 6 drugs, and only one drug (erlotinid hydrochloride) needed to be modified. The label rate of smoking affecting pharmacodynamics and pharmacokinetics was relatively low in Chinese drug instructions compared to US. It is suggested that the regulatory agent should standardize and improve related description in drug instruction, correct unsuitable content, revise the items which may result in severe consequence, and set up official website which can provide all drug instructions as soon as possible. Drug manufacturers should standardize clinical study of drugs before marketing, focus on the scientificity, completeness and normalization of drug instructions.
出处 《中国药房》 CAS 北大核心 2016年第25期3592-3595,共4页 China Pharmacy
基金 江苏省卫生国际(地区)交流支撑计划自选项目(No.苏卫国合[2012]36号)
关键词 处方药 药品说明书 吸烟 药效 药动学 Prescription drug Drug instructions Smoking Pharmacodynamics Pharmacokinetics
  • 相关文献

参考文献11

  • 1饶志,武新安.国内利巴韦林制剂说明书存在的问题[J].中国医院药学杂志,2011,31(13):1135-1137. 被引量:3
  • 2夏东胜.我国药品说明书儿童用药标示问题分析及风险控制建议[J].中国医院药学杂志,2014,34(22):1946-1951. 被引量:24
  • 3方顺干,沈浓儿,吴祖帅.336份药品说明书缺项统计分析[J].中国药房,2012,23(45):4315-4316. 被引量:8
  • 4洪宇.中国控烟政策变迁:基于支持联盟框架的分析[J].中国卫生政策研究,2014,7(3):20-26. 被引量:15
  • 5Li HB, Shi Q. Drugs and diseases interacting with ciga- rette smoking in US prescription drug labeling[J]. Clin Pharmacokinet, 2015,54 (5) : 493.
  • 6US Food and Drug Administration. Drug development and drug interactions: table of substrates, inhibitors and in- ducers[EB/OL]. (2014-10-27) [2015-11-05].http://www. fda.gov/drugs/developmentapprovalprocess/developmen- tresources/drugimeracfionslabeling/ucm093664.htm.
  • 7US Food and Drug Administration. Guidance for indus- try: drug interaction studies-study design, data analysis, and implications for dosing and labeling[EB/OL]. (2006- 09) [2015-11-06].http://www.fda.gov/ohrms/dockets/98fr/ 06d-0344-gd10001.pdf.
  • 8US Food and Drug Administration. Guidance for industry: drug interaction studies-study design, data analysis, im- plications for dosing, and labeling recommendations[EB/ OL]. ( 2012 -02 ) [2015-11-06] .http://www. fda.gov/down- loads/drugs/guidancecomplianceregulatoryinformation/ guidances/UCM292362.pdf.
  • 9国家食品药品监督管理局.化学药品和治疗用生物制品说明书规范细则[EB/OL].http://www.sfda.gov.cn/WS01/CL0055/10528.html.2006-05-10.
  • 10易湛苗,翟所迪.吸烟与药物相互作用[J].中国医院用药评价与分析,2009,9(10):793-795. 被引量:2

二级参考文献92

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部